VANGUARD HEALTH CARE FUND is a registered fund series of VANGUARD SPECIALIZED FUNDS (series S000002922). Net assets $36.9B as of 2026-04-30.
Showing 15 of 103 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $3.3B | 908.42% |
| Merck & Co Inc | — | $2.0B | 541.44% |
| AstraZeneca PLC | — | $1.9B | 509.40% |
| UnitedHealth Group Inc | — | $1.4B | 391.51% |
| Johnson & Johnson | — | $1.3B | 344.66% |
| Edwards Lifesciences Corp | — | $1.2B | 320.73% |
| GSK PLC | — | $1.2B | 312.97% |
| Intuitive Surgical Inc | — | $1.0B | 271.46% |
| Boston Scientific Corp | — | $868.2M | 235.54% |
| Danaher Corp | — | $865.5M | 234.80% |
| CVS Health Corp | — | $812.6M | 220.46% |
| Argenx SE | — | $812.6M | 220.44% |
| Abbott Laboratories | — | $802.8M | 217.78% |
| Vertex Pharmaceuticals Inc | — | $770.1M | 208.92% |
| Cencora Inc | — | $765.2M | 207.60% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $36.9B |
| 2026-01-31 | $39.3B |
| 2025-10-31 | $37.5B |
| 2025-07-31 | $34.3B |
| 2025-04-30 | $38.2B |
| 2025-01-31 | $41.9B |
| 2024-10-31 | $45.7B |
| 2024-07-31 | $48.8B |